Identify. Quantify. Predict. Why Immunologists Should Widely Use Molecular Imaging for Coronavirus Disease 2019
Molecular imaging using PET/CT or PET/MRI has evolved from an experimental imaging modality at its inception in 1972 to an integral component of diagnostic procedures in oncology, and, to lesser extent, in cardiology and neurology, by successfully offering in-vivo imaging and quantitation of key pat...
Main Authors: | Freimut D. Juengling, Antonio Maldonado, Frank Wuest, Thomas H. Schindler |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.568959/full |
Similar Items
-
A review on Coronavirus Disease and potentially active drugs targeting Coronavirus
by: Tarawanti Verma, et al.
Published: (2021-01-01) -
Simultaneous PET/MRI: The future gold standard for characterizing motor neuron disease—A clinico-radiological and neuroscientific perspective
by: Freimut D. Juengling, et al.
Published: (2022-08-01) -
Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?
by: Kavya Srinivasan, et al.
Published: (2021-11-01) -
Potentiating Cancer Immune Therapy via Nanomaterials and Purinergic Signaling
by: Davide Ferrari, et al.
Published: (2022-05-01) -
In Vitro Evidence of Statins’ Protective Role against COVID-19 Hallmarks
by: Donatella Fiore, et al.
Published: (2022-08-01)